Journey Clinical
5 known investors
Journey Clinical provides ketamine-assisted psychotherapy (KAP) for depression, anxiety, and PTSD, partnering patients with licensed therapists and medical teams while coordinating with major insurance providers.
Investors · 5
In the news
- Journey Clinical Raises $8.5M to Make the Benefits of Psychedelic-Assisted Therapies Accessible – AlleyWatchalleywatch.com · 2023
- Journey Clinical Raises $8.5M in Series A Fundingfinsmes.com · 2023
- Exclusive: Journey Clinical raises $9M to support psychedelic therapyaxios.com · 2023
- Journey Clinical's Series A | Union Square Venturesusv.com · 2023
- Journey Clinical raises $3M to allow psychotherapists to offer psychedelic therapies | TechCrunchtechcrunch.com · 2021